SONATA THERAPEUTICS Trademark

Trademark Overview


On Friday, May 20, 2022, a trademark application was filed for SONATA THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the SONATA THERAPEUTICS trademark a serial number of 97420640. The federal status of this trademark filing is REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED as of Friday, March 29, 2024. This trademark is owned by Sonata Therapeutics, Inc.. The SONATA THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical agents and products, namely, pharmaceutical agents for cellular signal modulation for treating cancer, fibrotic diseases, immune and inflammatory diseases, neurological diseases, infectious disease, tissue degenerative diseases, regenerative medicine; therapeutic products for cellular signal modulation in the nature of chemical and biological small molecules, namely, pharmaceutical preparations for the treatment of cancer; pharmaceutical compositions in the nature of chemical and biological small molecules, namely, pharmaceutical preparations for the treatment of cancer, fibrotic diseases, immune and inflammatory diseases, neurological diseases, infectious disease, tissue degenerative diseases, regenerative medicine; pharmaceutical compositions in the nature of chemical and biological molecules for cellular signal modulation, namely, pharmaceutical preparations for the treatment of cancer

Scientific research, pharmaceutical research, and medical research in the fields of pharmaceutical research and development and biotechnology for others; product development for others in the field of biotechnology; development of pharmaceuticals and therapeutic agents for others, namely, development of pharmaceutical preparations and medicines; technical scientific research consultation and product development for others in the field of biotechnology and development of pharmaceuticals; scientific research and development in the field of computational biology, bioinformatics, genomics, biotechnology and pharmaceuticals; platform as a service (PAAS) featuring computer software platforms for research and development of pharmaceutical data in the field of computational biology, bioinformatics, genomics, biotechnology and pharmaceuticals
sonata therapeutics

General Information


Serial Number97420640
Word MarkSONATA THERAPEUTICS
Filing DateFriday, May 20, 2022
Status654 - REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED
Status DateFriday, March 29, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical agents and products, namely, pharmaceutical agents for cellular signal modulation for treating cancer, fibrotic diseases, immune and inflammatory diseases, neurological diseases, infectious disease, tissue degenerative diseases, regenerative medicine; therapeutic products for cellular signal modulation in the nature of chemical and biological small molecules, namely, pharmaceutical preparations for the treatment of cancer; pharmaceutical compositions in the nature of chemical and biological small molecules, namely, pharmaceutical preparations for the treatment of cancer, fibrotic diseases, immune and inflammatory diseases, neurological diseases, infectious disease, tissue degenerative diseases, regenerative medicine; pharmaceutical compositions in the nature of chemical and biological molecules for cellular signal modulation, namely, pharmaceutical preparations for the treatment of cancer
Disclaimer with Predetermined Text"THERAPEUTICS"
Goods and ServicesScientific research, pharmaceutical research, and medical research in the fields of pharmaceutical research and development and biotechnology for others; product development for others in the field of biotechnology; development of pharmaceuticals and therapeutic agents for others, namely, development of pharmaceutical preparations and medicines; technical scientific research consultation and product development for others in the field of biotechnology and development of pharmaceuticals; scientific research and development in the field of computational biology, bioinformatics, genomics, biotechnology and pharmaceuticals; platform as a service (PAAS) featuring computer software platforms for research and development of pharmaceutical data in the field of computational biology, bioinformatics, genomics, biotechnology and pharmaceuticals

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 25, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, April 6, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSonata Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWatertown, MA 02472

Trademark Events


Event DateEvent Description
Tuesday, April 2, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 2, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, April 2, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, March 29, 2024REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, September 28, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, September 28, 2023LETTER OF SUSPENSION E-MAILED
Thursday, September 28, 2023SUSPENSION LETTER WRITTEN
Wednesday, August 23, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 23, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 23, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 23, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 23, 2023NON-FINAL ACTION E-MAILED
Tuesday, May 23, 2023NON-FINAL ACTION WRITTEN
Tuesday, April 25, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, April 25, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 25, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, April 6, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 5, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 5, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, April 3, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, April 3, 2023NON-FINAL ACTION E-MAILED
Monday, April 3, 2023NON-FINAL ACTION WRITTEN
Thursday, March 9, 2023ASSIGNED TO EXAMINER
Wednesday, May 25, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED